Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.64 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | PIM1 | P11309 | 1/20 | 0.57 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.57 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.57 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.57 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.57 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.54 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10438039 | 1.00 | PNP (0.64) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL10760495 | 0.89 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL10760521 | 0.89 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL10438068 | 0.89 | PNP (0.51) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL10438069 | 0.89 | PNP (0.51) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5983822 | 0.88 | PNP (0.67) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5983826 | 0.88 | PNP (0.67) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL998385 | 0.88 | PNP (0.78) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL3940787 | 0.88 | PNP (0.78) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5981918 | 0.88 | PNP (0.61) | PNPLMNATP53HTTPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 392 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215615-A1 | METHOD FOR EVALUATING DNA-ENCODED LIBRARY | NISSAN CHEMICAL CORPORATION (JP) | 2025-07-03 | — | — | US | claimed |
| US-20250146060-A1 | ECHO AMPLIFICATION: A COMPREHENSIVE SYSTEM OF CHEMISTRY AND METHODS FOR AMPLIFICATION AND DETECTION OF SPECIFIC NUCLEIC ACID SEQUENCES | CEPHEID | 2025-05-08 | — | — | US | claimed |
| US-12084715-B1 | Methods and systems for reducing artifactual antisense products | 10X GENOMICS, INC. (US) | 2024-09-10 | — | — | US | claimed |
| EP-4402284-A2 | ECHO AMPLIFICATION: A COMPREHENSIVE SYSTEM OF CHEMISTRY AND METHODS FOR AMPLIFICATION AND DETECTION OF SPECIFIC NUCLEIC ACID SEQUENCES | Cepheid (US) | 2024-07-24 | — | — | EP | claimed |
| US-20230212214-A1 | CLEAVABLE DNA-ENCODED LIBRARY | NISSAN CHEMICAL CORPORATION (JP) | 2023-07-06 | — | — | US | claimed |
| WO-2023095841-A1 | METHOD FOR EVALUATING DNA-ENCODED LIBRARY | 日産化学株式会社 | 2023-06-01 | — | — | WO | claimed |
| EP-4159766-A1 | CLEAVABLE DNA-ENCODED LIBRARY | Nissan Chemical Corporation (JP) | 2023-04-05 | — | — | EP | claimed |
| WO-2023043951-A2 | ECHO AMPLIFICATION: A COMPREHENSIVE SYSTEM OF CHEMISTRY AND METHODS FOR AMPLIFICATION AND DETECTION OF SPECIFIC NUCLEIC ACID SEQUENCES | CEPHEID (US) | 2023-03-23 | — | — | WO | claimed |
| CN-115461456-A | Cleavable DNA-encoded libraries | 日产化学株式会社 | 2022-12-09 | — | — | CN | claimed |
| US-20220282233-A1 | Cleavage of Single Stranded DNA Having a Modified Nucleotide | NEW ENGLAND BIOLABS, INC. (US) | 2022-09-08 | — | — | US | claimed |
| WO-2010030716-A1 | DETECTION OF NUCLEIC ACIDS BY OLIGONUCLEOTIDE PROBES CLEAVED IN PRESENCE OF ENDONUCLEASE V | KUTYAVIN IGOR (US) | 2010-03-18 | — | — | WO | claimed |
| EP-2158462-A1 | LOW RADIOCARBON DIETARY SUPPLEMENTS AND METHODS OF MAKING SAME | Radiocarb Genetics, Inc. (US) | 2010-03-03 | — | — | EP | claimed |
| US-20090318556-A1 | BIOMARKERS FOR DETECTING RADIATION EXPOSURE: METHODS AND USES THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2009-12-24 | — | — | US | claimed |
| WO-2008136793-A1 | LOW RADIOCARBON DIETARY SUPPLEMENTS AND METHODS OF MAKING SAME | WILLIAMS CHRISTOPHER P (US) | 2008-11-13 | — | — | WO | claimed |
| US-20070114476-A1 | Low radiocarbon nucleotide and amino acid dietary supplements | WILLIAMS CHRISTOPHER P | 2007-05-24 | — | — | US | claimed |
| WO-2007055860-A2 | LOW RADIOCARBON NUCLEOTIDE AND AMINO ACID DIETARY SUPPLEMENTS | WILLIAMS CHRISTOPHER P (US) | 2007-05-18 | — | — | WO | claimed |
| US-20070104761-A1 | Low radiocarbon nucleotide and amino acid dietary supplements | RADIOCARB GENETICS, INC. | 2007-05-10 | — | — | US | claimed |
| US-5565555-A | Nucleoside hydrogen phosphonodithioate diesters and activated phosphonodithioate analogues | GILEAD SCIENCES, INC. (US) | 1996-10-15 | — | — | US | claimed |
| EP-0360609-A2 | Novel hydrogen phosphonodithioate compositions | GILEAD SCIENCES, INC. (US) | 1990-03-28 | — | — | EP | claimed |
| US-4371613-A | TRANSARABINOSYLATION USING AN ENZYME FROM BACTERIA, AN ARABINOSE DONOR AND A PURINE SOURCE | AJINOMOTO COMPANY INCORPORATED (JP) | 1983-02-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318556-A1 | BIOMARKERS FOR DETECTING RADIATION EXPOSURE: METHODS AND USES THEREOF | OGG1, UNG, HPRT1 | PNP 152/4885LMNA 1709/4885TP53 1716/4885 |
| US-20230212214-A1 | CLEAVABLE DNA-ENCODED LIBRARY | FEN1, PCNA, UNG | PNP 403/4885LMNA 312/4885TP53 181/4885 |
| US-20070104761-A1 | Low radiocarbon nucleotide and amino acid dietary supplements | DNMT3B, DNMT3A, PCNA | PNP 123/4885LMNA 602/4885TP53 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.